Other
Payments for Repurchase of Common Stock
Thermo Fisher Scientific Payments for Repurchase of Common Stock increased by 50.0% to $3.00B in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalLower is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026May 1, 2026
How to read this metric
Higher spending indicates a commitment to returning capital to shareholders or offsetting dilution from stock-based compensation.
Detailed definition
The cash outflow associated with the company's repurchase of its own common shares from the open market. This is a prima...
Peer comparison
Standard capital return metric for mature public companies.
Metric ID:
other_payments_for_repurchase_of_common_stockHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $2.00B | $3.00B |
| QoQ Change | — | +50.0% |
| YoY Change | — | +50.0% |
Range$2.00B – $3.00B
Avg YoY Growth+50.0%
Median YoY Growth+50.0%
Payments for Repurchase of Common Stock at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's payments for repurchase of common stock?
- Thermo Fisher Scientific (TMO) reported payments for repurchase of common stock of $3.00B in Q1 2026.
- What does payments for repurchase of common stock mean?
- Cash spent by the company to buy back its own common stock.